Cargando…

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation

STUDY OBJECTIVE: To evaluate the efficacy and safety of aprepitant added to standard antiemetic regimens used in high-dose chemotherapy for allogeneic hematopoietic stem cell transplantation (allo-HSCT). DESIGN: Retrospective medical record review. SETTING: Hematology ward of a university hospital i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uchida, Mayako, Kato, Koji, Ikesue, Hiroaki, Ichinose, Kimiko, Hiraiwa, Hiromi, Sakurai, Asako, Muta, Tsuyoshi, Takenaka, Katsuto, Iwasaki, Hiromi, Miyamoto, Toshihiro, Teshima, Takanori, Shiratsuchi, Motoaki, Suetsugu, Kimitaka, Nagata, Kenichiro, Egashira, Nobuaki, Akashi, Koichi, Oishi, Ryozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817520/ https://www.ncbi.nlm.nih.gov/pubmed/23712662 http://dx.doi.org/10.1002/phar.1294

Ejemplares similares

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
por: Uchida, Mayako, et al.
Publicado: (2018)

Impact of CYP3A5, POR, and CYP2C19 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplantation
por: Suetsugu, Kimitaka, et al.
Publicado: (2019)

Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats
por: Mihara, Yuki, et al.
Publicado: (2011)

Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study
por: Suetsugu, Kimitaka, et al.
Publicado: (2021)

Detection of overdose and underdose prescriptions—An unsupervised machine learning approach
por: Nagata, Kenichiro, et al.
Publicado: (2021)

Tyrosine kinase inhibitors induce alternative spliced BCR‐ABL (Ins35bp) variant via inhibition of RNA polymerase II on genomic BCR‐ABL
por: Yuda, Junichiro, et al.
Publicado: (2020)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015)

Recent advances in the diagnosis and management of primary myelofibrosis
por: Takenaka, Katsuto, et al.
Publicado: (2018)

Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation
por: Nakamura, Takahiro, et al.
Publicado: (2020)

Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy
por: Matsukane, Ryosuke, et al.
Publicado: (2021)

Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeficient Mouse Model with Kit(Wv) Mutations
por: Yurino, Ayano, et al.
Publicado: (2016)

Differences in recognition of similar medication names between pharmacists and nurses: a retrospective study
por: Tsuji, Toshikazu, et al.
Publicado: (2015)

Expansion of NKG2C-expressing Natural Killer Cells after Umbilical Cord Blood Transplantation in a Patient with Peripheral T-cell Lymphoma with Cytotoxic Molecules
por: Muta, Tsuyoshi, et al.
Publicado: (2017)

L type Ca(2+ )channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats
por: Kawashiri, Takehiro, et al.
Publicado: (2012)

Inhibition of Ca(2+)/Calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in Rats
por: Shirahama, Masafumi, et al.
Publicado: (2012)

Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor
por: Mori, Yasuo, et al.
Publicado: (2009)

Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation
por: Sakoda, Teppei, et al.
Publicado: (2017)

Neutrophil Gelatinase-Associated Lipocalin Is Not Associated with Tacrolimus-Induced Acute Kidney Injury in Liver Transplant Patients Who Received Mycophenolate Mofetil with Delayed Introduction of Tacrolimus
por: Fukuda, Mio, et al.
Publicado: (2019)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Treatment for Refractory Pruritus Using Oral Aprepitant
por: Huh, Joon Won, et al.
Publicado: (2016)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome
por: Parvataneni, Swetha, et al.
Publicado: (2019)

Nanomedicines in the treatment of emesis during chemotherapy: focus on aprepitant
por: Olver, Ian, et al.
Publicado: (2007)

Preparation and Characterization of Nanosuspension of Aprepitant by H96 Process
por: Kalvakuntla, Sunethra, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus(®)
por: Liu, Jinwen, et al.
Publicado: (2015)

Comparison of Pharmacokinetics of Aprepitant in Healthy Chinese and Caucasian Subjects
por: Yang, Meng-Jie, et al.
Publicado: (2020)

Effectiveness of aprepitant in post‐acute COVID19 syndrome
por: Reinoso‐Arija, Rocío, et al.
Publicado: (2021)

Preparation and Characterization of Aprepitant Solid Dispersion with HPMCAS-LF
por: Liu, Jinwen, et al.
Publicado: (2022)

In Vitro Biological Evaluation of Aprepitant Based (177)Lu-Radioconjugates
por: Halik, Paweł K., et al.
Publicado: (2022)

Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
por: Jin, Yilan, et al.
Publicado: (2021)

Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events
por: Matsukane, Ryosuke, et al.
Publicado: (2021)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Efficacy analysis of the aprepitant-combined antiemetic prophylaxis for non-round cell soft-tissue sarcoma patients received adriamycin and ifosfamide therapy
por: Kusaba, Hitoshi, et al.
Publicado: (2016)

Enforced Granulocyte/Macrophage Colony-stimulating Factor Signals Do Not Support Lymphopoiesis, but Instruct Lymphoid to Myelomonocytic Lineage Conversion
por: Iwasaki-Arai, Junko, et al.
Publicado: (2003)

Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy
por: Ständer, Sonja, et al.
Publicado: (2010)

Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting
por: Chrisp, Paul
Publicado: (2007)

Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients
por: Fujiwara, Yutaka, et al.
Publicado: (2014)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o3kev3m03h74kfgfsqb4v6mbo0